Harms, H K <br/><br/>
Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group.  [electronic resource] 

 -  Pediatric pulmonology  Sep 1998 
 - 155-61 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>8755-6863 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1099-0496(199809)26:3<155::aid-ppul1>3.0.co;2-k  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adolescent<br/>Adult<br/>Child<br/>Child, Preschool<br/>Cystic Fibrosis--drug therapy<br/>Deoxyribonuclease I--administration & dosage<br/>Expectorants--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Recombinant Proteins--administration & dosage<br/>Respiratory Function Tests<br/>Treatment Outcome